Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fuda Cancer Hospital specializes in minimally invasive oncology treatments for medium and advanced-stage cancers. It has pioneered cryosurgical ablation in China and treats patients from over 100 countries. The hospital reports improved survival rates for advanced cases using its combination of cryoablation, interventional therapies like CMI and CIC immunotherapy—including NK cell therapy and CAR-T cell therapy—and personalized regimens. It has received national recognition for clinical excellence but some patient reviews note variable experiences with outcomes and care standards[1][2][4][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fuda Cancer Hospital.